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Trichomonas vaginalis, a flagellate protozoan, is the causative agent of trichomonosis, the most common nonviral sexually trans-
mitted disease worldwide. Taking into account the increased prevalence of metronidazole-resistant isolates, alternative drugs are
essential for the successful treatment. Natural products are the source of most new drugs, and popular wisdom about the use
of medicinal plants is a powerful tool in this search. In this study, the activity of 10 medicinal plants extensively used in daily
life by Mbyá-Guarani indigenous group was evaluated against seven different T. vaginalis isolates. Among the aqueous extracts
tested,Verbena sp. (Guachu ka’a inMbyá-Guarani language) andCampomanesia xanthocarpa (Guavira inMbyá-Guarani language)
showed the highest activity against T. vaginalis with MIC value of 4.0mg/mL reaching 100% of efficacy against the parasite. The
kinetic growth assays showed that the extracts promoted complete growth abolishment after 4 h of incubation. In addition, the
extracts tested did not promote a significant hemolytic activity against human erythrocytes. Our results show for the first time
the potential activity of Verbena sp. and C. xanthocarpa against T. vaginalis. In addition, this study demonstrates that indigenous
knowledge is an important source of new prototype antiprotozoal agents.
1. Introduction
Trichomonas vaginalis parasitizes the urogenital human tract
causing trichomonosis, the most prevalent non-viral sexually
transmitted diseaseworldwide, being responsible for 248mil-
lion new cases annually [1]. After colonization, the parasite
causes vaginitis, urethritis, and prostatitis [2]. Moreover, the
pathogen has been associated with serious consequences as
adverse pregnancy outcomes and preterm birth [3], infertility
[4], predisposition to cervical cancer [5], and pelvic inflam-
matory disease [6]. Importantly, trichomonosis acts as a
cofactor in human immunodeficiency virus (HIV) transmis-
sion and acquisition [7, 8]. In spite of impact of this infection,
the therapeutic arsenal is restricting, and only metronidazole
and tinidazole, both 5-nitroimidazole drugs, are approved by
the FDA for trichomonosis treatment [9]. Although the cure
rate is high, treatment failure can be observed and the resis-
tance of T. vaginalis isolates is the main reason of treatment
failure [10]. In this sense, it is undoubtedly necessary that
the investigation for new alternatives for the treatment of
trichomonosis and two strategies can be followed: (i) the
search for new therapeutic targets, which is essential to
rational development of new antiparasitic agents and (ii) the
investigation of new anti-T. vaginalis compounds structurally
distinct from 5-nitroimidazoles and, consequently, acting by
different mechanism as demonstrated by our group [11, 12].
In this context, natural products, especially medicinal
plants, are immeasurable as a potent source of bioactive
molecules. Since ancient times, people use plants to treat
common infectious diseases, and some of these traditional
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medicines are still integrated as part of the cure of diverse
pathologies [13]. In addition, the search based on ethnophar-
macological information rescues the immense empirical
knowledge of plants utilization [14, 15]. In this context,
regarding natural environment and vast wealth of genetic
resources, Brazil is a country of great interest to ethnophar-
macology [16].
Indigenous people have a wealth of biodiversity informa-
tion and know how to capture and use natural resources [17].
Despite of the fact that several drugs have been discovered
through traditional cures and folk knowledge, in Brazil there
are 122 indigenous ethnic groups, but only 30% of them were
investigated with regard to ethnobotanical aspects [18, 19].
Therefore, the study of plants used by indigenous medicine
is important to interconnect traditional medicine and biotic
environment preserving the indigenous ancient knowledge.
Parasitic protozoa remain a major threat to human and
animal health, and there are few effective drugs for the
treatment of many protozoal diseases. Taking into account
the indigenous ethnopharmacology as a contributor to the
systematic screening of plants with antiprotozoal activity, this
study evaluated the anti-T. vaginalis activity of the most
important medicinal plants used in Mbyá-Guarani indige-
nous medicine located in South of Brazil.
2. Materials and Methods
2.1. Parasite Culture Conditions. In this study, seven isolates
of T. vaginalis were used: 30236 and 30238 from American
Type Culture Collection (ATCC); TV-LACM1, TV-LACM2,
and TV-LACM3 (fresh clinical isolates from female patients);
TV-LACH1 andTV-LACH2 (fresh clinical isolates frommale
patients) all from Laboratório de Análises Cĺınicas e Tox-
icológicas, Faculdade de Farmácia, UFRGS, Brazil (project
with ethical approval by UFRGS Ethical Research Commit-
tee, number 18923). Trichomonads were axenically cultured
in trypticase-yeast extract-maltose (TYM)medium (pH 6.0),
supplemented with 10% heat-inactivated bovine serum and
incubated at 37∘C [20].
2.2. PlantMaterial. Plantmaterialwas collected from indige-
nous tribe Mbyá-Guarani located at the Lomba do Pinheiro,
Porto Alegre, RS, Brazil (30∘06󸀠47.62󸀠󸀠 S and 51∘07󸀠37.85󸀠󸀠W),
inMarch 2011.This village is denominated Tekoá Anhetenguá
(in English,TrueVillage), and 200 people live in the area gath-
ered at 40 families.The women of the village have the knowl-
edge of medicinal plants used by the entire population and
conducted the collection of specimens. Ten plants routinely
used in indigenous medicine for infectious diseases were
collected: leaves of Aloe arborescensMill. (ICN 173371), aerial
parts of Bidens pilosa L. (ICN 167397), aerial parts ofRhipsalis
baccifera (ICN 167402), barks of Luehea divaricata (ICN
167403), roots of Trichilia sp. (ICN 173126), leaves of Campo-
manesia xanthocarpa O. Berg. (ICN 167401), leaves of Coix
lacryma-jobi Lin. (ICN 167396), leaves of Citrus limonium
(ICN 167399), leaves of Citrus reticulata (ICN 173127), and
leaves of Verbena sp. (ICN 167394). The voucher specimens
were deposited at the herbarium of the Universidade Federal
do Rio Grande do Sul (ICN).
2.3. Preparation of Plant Extracts. The fresh plants extracts
were prepared conforming traditional use by indigenous peo-
ple by decoction at 60∘C for 60min [1 : 10; (w : v)]. Aqueous
extracts were freeze dried, and the work solution was pre-
pared at 8.0mg/mL in ultrapure water, sterilized by filtration
(0.22 𝜇m) and stored at −20∘C.
2.4. Anti-Trichomonas vaginalis Assay. Ten aqueous extracts
were screened in vitro for activity against T. vaginalis. The
assay was performed in 96 microtiter plates at final concen-
tration of 4.0mg/mL in the wells. The inhibitory minimum
concentration (MIC)was determined using an eightfold dilu-
tion (4.0–0.031mg/mL), and the viability of the trophozoites
was determined according to a fluorimetricmethod [21]. Two
controls were performed: negative control only with tropho-
zoites and a positive control with 8.0𝜇M metronidazole
(Sigma Chemical Co., St. Louis, MO, USA).The experiments
were performed at least in three independent experiments,
in triplicate. The results were expressed as the percentage of
viable trophozoites compared to untreated parasites.
2.5. Growth Effect of Aqueous Extracts. In order to investigate
the effect of the active aqueous extracts on T. vaginalis
growth, a kinetic growth curve was performed using the
ATCC 30236 isolate. The parasites initial density of 2.0 ×
105 trophozoites/mL was incubated with the extracts at MIC
value in TYMmedium.The trophozoites were counted using
a hemocytometer during 72 h. The results were expressed as
trophozoite number (105/mL). For microscopic analysis, the
controls and treated parasites were centrifuged for 10min at
2,000 rpm to concentrate the organisms after 4 h of incuba-
tion, and the preparation was observed in light microscope
(magnified ×1,000) by trypan blue dye exclusion.
2.6. Hemolytic Assay. This assay was performed according to
the method used by Rocha et al. [22]. Blood type O positive
from healthy human volunteers was collected with Alsever’s
solution (1 : 1) and centrifuged at 2,000 rpm for 5min. The
erythrocyte fraction was washed three times with PBS 1x (pH
7.0) and resuspended to give 1% red cell suspension (v/v).
Aqueous extracts concentrations were chosen according to
minimum inhibitory concentration (MIC) determined in the
susceptibility assay.The erythrocytes were incubated with the
extracts at 37∘C under agitation for 1 h and then were cen-
trifuged at 3,000 rpm for 5min.The absorbance of the super-
natant was measured at 540 nm. The experiment was per-
formed in triplicate, and the percentage of hemolysis caused
by each sample tested was calculated in comparison to 100%
hemolytic activity of saponin from Quillaja saponaria [23].
3. Results and Discussion
This study evaluated the anti-T. vaginalis activity of aqueous
extracts of 10 medicinal plants used in medicine system
Mbyá-Guarani. Importantly, among the plants tested, we
found two aqueous extracts with a potent anti-T. vaginalis in
vitro activity. The promising extracts are of Verbena sp. and
Campomanesia xanthocarpa. The extract from Verbena sp.,









































































































































































































































































































































































































































































































































































Figure 1: Effect of selected Mbyá-Guarani medicinal plants at 4.0mg/mL on different Trichomonas vaginalis isolates. (a) Verbena sp. (b)
Campomanesia xanthocarpa. (c) Bidens pilosa. (d) Luehea divaricata. (e) Coix lacryma-jobi. (f) Trichilia sp. (g) Citrus limonium. (h) Aloe
arborescens. (i) Citrus reticulata. (j) Rhipsalis baccifera. Data represent means ± standard deviation.
Table 1: Hemolytic activity of the aqueous extracts that showed
the best anti-Trichomonas vaginalis activity and respective MIC
determined by susceptibility assay.
Aqueous extract
Verbena sp. Campomanesia xanthocarpa
MIC (mg/mL) 4.0 4.0
Hemolysis (%) ± S.D. 6.5 ± 0.02 7.6 ± 0.01
at 4.0mg/mL, demonstrated the optimal anti-T. vaginalis
activity inducing complete cytotoxicity (100% of parasites
death) upon all distinct trichomonads isolates (Figure 1(a)).
The leaves extract of Campomanesia xanthocarpa at the same
concentration also showed a very high anti-T. vaginalis activ-
ity, reducing the parasite viability up to 96% (Figure 1(b)).
Other aqueous extracts displayed a variety of results.
The aqueous extract obtained from Bidens pilosa totally
abolished the trophozoites viability only of the 30236 isolate
(Figure 1(c)). The extract of the barks of Luehea divaricata
induced a reduction ofT. vaginalis viability differently in each
trichomonads isolate tested (Figure 1(d)). The leaves of Coix
lacryma-jobi induced, on average, 75% of viability reduction
on T. vaginalis isolates; however, for the TV-LACH2 isolate,
the reduction was only 40% (Figure 1(e)). The fresh clinical
isolates from male patients (TV-LACH1 and TV-LACH2)
presented higher susceptibility than the isolates from female
patients (ATCC and fresh clinical) when the root extract of
Trichilia sp. was tested (Figure 1(f)). Extracts of leaves from
Citrus limonium reduced about 40% the viability of isolates
(Figure 1(g)). The extracts from Aloe arborescens and Citrus
reticulata decreased the viability of 50% of at least one isolate
(Figures 1(h) and 1(i)), while Rhipsalis baccifera reduced
only 30% the viability of 30236 and TV-LACM2 isolates
(Figure 1(j)).
In comparison to the other extracts, the extracts fromVer-
bena sp. and C. xanthocarpa demonstrated the most promis-
ing activity against T. vaginalis, and the minimum inhibitory
concentration was determined for the 30236 isolate (Table 1).
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Figure 2: Kinetic growth curve of Trichomonas vaginalis 30236 iso-
late after treatment with aqueous extracts ofVerbena sp. andCampo-
manesia xanthocarpa at 4.0mg/mL. The trophozoites growth was
completely inhibited by the extracts in 4 hours of incubation. Data
represent means ± standard deviation of at least three experiments,
all in triplicate.
In order to investigate the effect of the most active extract
on parasite growth and viability, a kinetic growth curve was
performed. The control exhibited the classical growth peak
after 24 h of incubation; however, the organisms treated with
extracts of Verbena sp. and C. xanthocarpa, after 4 h of incu-
bation, evoked a complete growth abolishment (Figure 2) and
showed a characteristic blue color by trypan blue dye exclu-
sion indicating cell death (Figure 3).
In order to investigate a possible effect of the C. xantho-
carpa and Verbena sp. extracts on parasites membrane and
also to have preliminary data on cytotoxicity against mam-
malian cells, hemolytic activity of these extracts was con-
ducted. The Verbena sp. and C. xanthocarpa extracts were
tested at MIC values and demonstrated 6.5 and 7.6% erythro-
cytes lysis, respectively (Table 1). These results demonstrated
that both extracts, at MIC values, did not promote a signif-
icant hemolytic activity, indicating that the mechanism of
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(a) Control (b) Verbena sp.
(c) Campomanesia xanthocarpa
Figure 3: Microscopic analysis of parasites morphology in light microscope (magnified ×1,000) by trypan blue dye exclusion. (a) Control;
(b) after 4 hours of treatment with aqueous extract of Verbena sp.; (c) after 4 hours of treatment with aqueous extract of Campomanesia
xanthocarpa.
action responsible for the parasite viability reduction proba-
bly does not involve parasitic membrane disruption. More-
over and importantly, these findings suggest that both ex-
tracts are not toxic to mammalian cells, since they did not
lyse human erythrocytes.
This study contributes to rescue the indigenous knowl-
edge about medicinal plants. The indigenous Mbyá-Guarani
use Verbena sp. (Guachu ka’a in Mbyá-Guarani language),
as tea, for relief of symptoms of infectious diseases, such as
fever.This is in agreement of the literature that relatesVerbena
sp. infusion as sedative, analgesic to inflammatory disorders,
skin burns, amenorrhea, depression, and gastric diseases [24–
26]. Moreover, this species has a variety of chemical con-
stituents, as flavonoid, iridoid glycosides, phenylpropanoid
glycoside, sterols, triterpenes, and glycoconjugate, and the
biological activity may be partially attributed to them [24].
In addition, this tribe utilizes the leaves of C. xanthocarpa
(Guavira in Mbyá-Guarani language) for treatment of diar-
rhea, stomach pain, and worms. This plant is traditionally
used in the south of Brazil as depurative, antidiarrhoeic,
cleanser, and antirheumatic, and to decrease the blood
cholesterol [27], and these properties may be attributed
to tannins, saponins, and flavonoids (quercetin, myricetin,
quercitrin, and rutin), compounds present in the leaves of C.
xanthocarpa [28].
The rescue ethnopharmacology of historical uses of plants
is recognized as valuable for bioprospection, since they afford
the rationale for selection and research of medicinal plants
[15].This study describes the first report on the antiprotozoal
activity of Verbena sp. and C. xanthocarpa. In addition, other
species of the families Verbenaceae and Myrtaceae were
tested against T. vaginalis, however, without success [29, 30].
Several biodiversities and traditional knowledge of different
populations have guided studies to search new prototypes
anti-T. vaginalis. Recently, the potential of plants traditionally
used from Caatinga against T. vaginalis was reported [31].
Calzada et al. [29] demonstrated that plants used for urogen-
ital tract disorders in Mexican traditional medicine showed
effect against this protozoan. Amaryllidaceae species used
against venereal diseases in SouthAfrica also showed promis-
ing activity against T. vaginalis [11, 32].
Considering the impact of trichomonosis in public health
and the emergent number of resistantT. vaginalis isolates, it is
necessary alternatives for the treatment of this infection. Nat-
ural products are a promising source of active molecules, and
the ethnopharmacology approach rescues the knowledge of
population of medicinal plants. This wisdom combined with
chemical and pharmacological studies presents a precious
value in the bioprospection of innovates, safe, and accessible
drugs.This pioneer study demonstrated relevant results about
anti-T. vaginalis activity of the Verbena sp. and C. xantho-
carpa, plants traditionally used by indigenous population
Mbyá-Guarani for infectious diseases. Despite of showing
strong anti-T. vaginalis activity, this report rescued the knowl-
edge of indigenous people, avoiding the miscarriage of this
wisdom.
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